Healthcare provider profile · identity verified

Lance C. Brunner, MD

Family Practice · ANAHEIM, CA · NPI 1003987900

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	277	91
Levothyroxine Sodium	Levothyroxine Sodium	246	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	218	35
Losartan Potassium	Losartan Potassium	142	43
Rosuvastatin Calcium	Rosuvastatin Calcium	125	40
Amlodipine Besylate	Amlodipine Besylate	120	37
Potassium Chloride	Potassium Chloride	111	37
Gabapentin	Gabapentin	106	29
Metformin Hcl Er	Metformin Hcl	96	33
Albuterol Sulfate Hfa	Albuterol Sulfate	90	34
Pantoprazole Sodium	Pantoprazole Sodium	89	29
Omeprazole	Omeprazole	81	29
Prednisone	Prednisone	77	34
Furosemide	Furosemide	75	29
Metoprolol Tartrate	Metoprolol Tartrate	73	21
Atenolol	Atenolol	71	22
Famotidine	Famotidine	66	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	19
Donepezil Hcl	Donepezil Hcl	63	13
Wixela Inhub	Fluticasone Propion/Salmeterol	63	26
Alendronate Sodium	Alendronate Sodium	61	17
Montelukast Sodium	Montelukast Sodium	60	16
Trazodone Hcl	Trazodone Hcl	59	21
Buspirone Hcl	Buspirone Hcl	58	17
Lisinopril	Lisinopril	58	20
Alprazolam	Alprazolam	55	suppressed
Ezetimibe	Ezetimibe	55	17
Jardiance	Empagliflozin	55	18
Sucralfate	Sucralfate	54	18
Duloxetine Hcl	Duloxetine Hcl	50	13
Glipizide	Glipizide	50	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Simvastatin	Simvastatin	48	15
Tamsulosin Hcl	Tamsulosin Hcl	47	16
Metformin Hcl	Metformin Hcl	46	17
Morphine Sulfate	Morphine Sulfate	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	15
Hydrocortisone	Hydrocortisone	42	25
Mupirocin	Mupirocin	42	21
Ipratropium Bromide	Ipratropium Bromide	41	18
Sertraline Hcl	Sertraline Hcl	41	15
Allopurinol	Allopurinol	40	12
Lactulose	Lactulose	39	15
Terazosin Hcl	Terazosin Hcl	39	11
Finasteride	Finasteride	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	20
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	36	13
Fluticasone Propionate	Fluticasone Propionate	35	14
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Cephalexin	Cephalexin	34	21
Doxycycline Monohydrate	Doxycycline Monohydrate	34	21
Ondansetron Odt	Ondansetron	33	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	31	31
Lidocaine	Lidocaine	31	17
Lorazepam	Lorazepam	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Meloxicam	Meloxicam	30	12
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Trospium Chloride	Trospium Chloride	30	suppressed
Mirtazapine	Mirtazapine	29	14
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Nystatin	Nystatin	24	11
Celecoxib	Celecoxib	23	suppressed
Ozempic	Semaglutide	22	suppressed
Amoxicillin	Amoxicillin	21	12
Azelastine Hcl	Azelastine Hcl	21	suppressed
Naproxen	Naproxen	21	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Nabumetone	Nabumetone	20	11
Azithromycin	Azithromycin	19	18
Fentanyl	Fentanyl	19	suppressed
Humulin N	Insulin Nph Human Isophane	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Sulindac	Sulindac	19	suppressed
Baclofen	Baclofen	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	15
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Cefadroxil	Cefadroxil	14	12
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Eliquis	Apixaban	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Etodolac	Etodolac	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Sitagliptin	Sitagliptin	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Tadalafil	Tadalafil	11	suppressed
Temazepam	Temazepam	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error